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Abstract PTP-S2 is a widely expressed nuclear protein tyrosine 
phosphatase which shows increased expression upon mitogenic 
stimulation of a variety of cells. In order to elucidate the role of 
this enzyme in cell division, stable clones of HeLa cells 
expressing rat PTP-S2 were isolated and their growth properties 
analysed. Overexpressed PTP-S2 was located in the cell nucleus 
and there was no significant change in the total tyrosine 
phosphatase activity of PTP-S2 overexpressing cells. PTP-S2 
overexpressing clones, D3 and B5, showed increased rate of cell 
division and lower serum requirement as compared with control 
cells. D3 and B5 cells formed larger colonies in soft agar, were 
not contact inhibited upon confhiency, grew in multilayers, and 
showed altered morphology. These results are consistent with the 
suggestion that PTP-S2 may be a positive regulator of cell 
proliferation. 
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1. Introduction 
The major product encoded by the rat PTP-S gene is the 
PTP-S2 isoform which is a PTPase that binds D N A in vitro 
and is located in the nucleus in association with chromatin [ 1 -
5]. Another isoform arising from the same gene by alternative 
splicing is PTP-S4 that differs from PTP-S2 in enzymatic ac-
tivity, subcellular localization and inability to bind D N A [4,5]. 
Both PTP-S2 and PTP-S4 m R N A s are widely expressed in 
various tissues and cell lines [5]. In all cases, PTP-S2 
m R N A level was found to be 2-10-fold higher than the 
PTP-S4 m R N A level [5]. Earlier work in our laboratory 
showed that PTP-S m R N A is induced in the absence of de 
novo protein synthesis, upon mitogenic stimulation of resting 
lymphocytes [6]. The time course of induction in stimulated 
lymphocytes, and serum-stimulated cells in culture showed 
that peak levels of m R N A are attained at late G l phase of 
the cell cycle [6-8]. In these experiments PTP-S m R N A levels 
were compared by Nor thern blotting and individual isoforms 
were not analysed. Subsequently we have shown that both 
PTP-S2 and PTP-S4 isoforms are induced during liver regen-
eration after 6 h (G l phase) of partial hepatectomy [5]. 
Since the level of PTP-S2 m R N A is transiently increased 
upon mitogenic stimulation, it was possible that this PTPase 
may play a role in cell proliferation. In order to explore this 
possibility, in this study we have analysed the effect of over-
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expression of PTP-S2 on the growth properties of established 
cell lines. HeLa cells overexpressing rat PTP-S2 grew faster, 
showed altered morphology and formed larger colonies in soft 
agar. Our results suggest that overexpression of PTP-S2 af-
fects cell growth. 
2. Materials and methods 
2.1. Plasmids 
Construction of expression plasmid pCB6-PTP-S2 has been de-
scribed previously [5]. This construct expresses PTP-S2 protein under 
the control of cytomegalovirus promoter. 
2.2. Cell culture, transfection and stable cell lines 
Unless otherwise mentioned, all cell lines were normally maintained 
in Dulbecco's modified Eagle's medium (DMEM) with 10% FCS (fe-
tal calf serum) in a humidified C0 2 incubator at 37°C. Transfections 
were performed using Lipofectin or Lipofectamine reagents (Gibco-
BRL) as per the manufacturer's instructions. Briefly, cells were seeded 
24 h prior to transfection to reach 70% confhiency. Plasmid DNA (2 
(ig) and Lipofectin or Lipofectamine (12 ul) were mixed in 2 ml of 
serum-free medium, left for 30 min at room temperature and then 
overlayed on the cell monolayer. Six hours later, an equal volume 
of medium containing 20%> FCS was added. To obtain stable cell 
lines, HeLa cells were transfected with pCB6-PTP-S2 (as described 
earlier) and after 48 h, medium was changed and cells maintained 
in DMEM containing 10% FCS and 500 ug/ml Geneticin (Sigma). 
The Geneticin-resistant colonies formed were transferred to 24-well 
plates and propagated. Expression of recombinant rat PTP-S2 was 
monitored by indirect immunofluorescence and Western blotting as 
described earlier using a monoclonal antibody, Gl 1 which recognises 
rat PTP-S proteins but not the human PTP-S proteins [3,5], Two 
clones that showed stable expression after repeated passages were 
selected for further study. HeLa cells and a HeLa cell line that is 
Geneticin resistant but shows no expression of recombinant PTP-S2 
were used as controls (nr HeLa 1). 
2.3. Colony formation assay 
Colony formation assay was performed as described by Hansen and 
Braithwaite [9], About 3 X 105 COS-1 cells or 4X 105 HeLa cells were 
plated in 60 mm petri dishes and 24 h later transfected with 2.5 ug of 
either pCB-6 or pCB6-PTP-S2 plasmid DNA using Lipofectin re-
agent. After 48 h of transfection, cells were maintained in DMEM 
containing 10% FCS and 400 (ig/ml Geneticin for 14-16 days. Cells 
were then fixed and stained with 0.4%> sulphorhodamine B (Sigma) in 
1% acetic acid and the number and size of colonies monitored. 
2.4. Determination of growth kinetics 
PTP-S2 overexpressing clones and control cells (1X10°) were 
seeded in duplicate 35 mm petri dishes in DMEM with 10% FCS. 
On consecutive days, cells were harvested with trypsin, dispersed and 
counted using a hemocytometer. For determination of saturation den-
sity, cells were fed regularly with fresh medium and allowed to grow 
post-confluence. Four days after attaining confluency, the number of 
viable cells was counted. 
Serum requirement of various cell lines was monitored by assessing 
growth of cells in medium containing 0%, 1%, 2%, 4% or 10% serum. 
Cells (1 X 10°) were plated in duplicate 35 mm dishes in DMEM with 
10% FCS. After 24 h, plates were washed 5 times with PBS and 
replaced with medium containing different serum concentrations. Via-
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ble cell number was determined after 4 days of growth in the given 
serum concentration. 
2.5. Soft agar assay 
Cells (1 X 105) were suspended in 1.5 ml of DMEM with 10% FCS 
and 0.33% agar (Sigma) and plated in 60 mm dishes containing a 
basal layer of 0.5% agar in DMEM with 10% FCS. Plates were in-
cubated for 2 weeks at 37°C in 5% CO2. Cultures were fed weekly 
with 1.5 ml of DMEM containing 10% FCS and 0.33% agar. At the 
end of 2 weeks, colonies were photographed on an inverted light 
microscope at 50 X magnification. 
2.6. Other methods 
Immunoblotting, immunoprecipitation and immunofluorescence 
staining with anti-PTP-S monoclonal antibody was carried out as 
described [3]. Protein tyrosine phosphatase assays were carried out 
as described [10] using 32P-labelled poly^lu^Tyr1) as substrate ex-
cept that during the assay 1 mM dithiothreitol was added instead of 
2-mercaptoethanol. 
3. Results 
To identify the effects of expression of exogenous PTP-S2 
on cell survival and growth, COS-1 and HeLa cells were 
transfected with either the control plasmid or plasmid encod-
ing full-length PTP-S2. Transfected cells were selected with 
Geneticin and 14—16 days later cell growth was assessed by 
counting the number of large colonies which arose from trans-
fected cells. (Fig. 1). In case of COS-1 cells, PTP-S2 plasmid 
gave 13.0±1.7 (meantSE, M = 6) large colonies and control 
plasmid gave 6.211.1 (» = 6) large colonies. With HeLa cells 
PTP-S2 plasmid gave 13.0 ±0.9 (« = 3) large colonies whereas 
control plasmid gave 5.7 ±0.3 (M = 3 ) large colonies. Thus the 
number of large colonies was about 2-fold higher when the 
cells were transfected with PTP-S2 plasmid as compared with 
the control plasmid. This increase in the number of large 
colonies with PTP-S2 plasmid is not due to higher efficiency 
of transfection since the total number of Geneticin-resistant 
colonies (large and small) was essentially the same with con-
trol or PTP-S2 plasmid. This result, therefore, indicated that 
PTP-S2 overexpression promotes growth of cells. 
Fig. 1. Colony formation assay of COS-1 and HeLa cells transfected 
with either pCB6 control plasmid or pCB6-PTP-S2. After 14-16 
days of selection in Geneticin, cells were stained with sulforhod-
amine B and cell growth was assessed by observing the number and 
size of colonies. 
Fig. 2. Immunoblot showing expression of rat PTP-S2 in overex-
pressing and control cells. A: Coomassie blue-stained gel showing 
protein profile of lysates used for blot in (B). The doublet seen in 
lane marked Fl 11 are the endogenous rat PTP-S polypeptides. 
HeLa cells were transfected with the full-length cDNA en-
coding the rat PTP-S2 isoform in an expression vector pCB6, 
and Geneticin-resistant cell lines were isolated. PTP-S2 ex-
pression in the clones was tested by immunofluorescence 
and Western blotting using a previously characterised mono-
clonal antibody which recognises the rat as well as the mouse 
PTP-S proteins but not human proteins [3]. Majority of the 
clones expressed the recombinant protein but only in about 1-
5% of the cells. The clones D3 and B5 that expressed PTP-S2 
in more than 30% of the cells were selected for further study. 
Fig. 2 shows the expression of PTP-S2 in HeLa, nr HeLal, D3 
and B5 clones as determined by immunoblotting. For the 
purpose of comparison, lysate of rat fibroblast cell line F i l l 
was also included, which showed a doublet; the lower band of 
about 45 kDa corresponds to PTP-S2. Immunofluorescence 
analysis showed that PTP-S2 is present in the nucleus (Fig. 
3A) as was shown previously in transiently transfected HeLa 
cells and fibroblasts. This suggests that PTP-S2 protein com-
partmentalizes properly in the stably transfected cells. Over-
expressed PTP-S2 in D3 and B5 cells constitutes about 0.04% 
of the total PTPase activity as determined by estimating 
PTPase activity in the PTP-S2 immunoprecipitates. The over-
all PTPase activity of D3 and B5 cell extracts showed no 
significant change as compared to HeLa cells (data not 
shown). 
The PTP-S2 overexpressing clones D3 and B5, and control 
cell lines were studied for comparison of morphology and 
growth rates. In subconfluent cultures D3 and B5 cells looked 
similar to HeLa cells (Fig. 3B). However in confluent cultures, 
unlike control cells, D3 and B5 cells were not growth arrested 
due to contact inhibition and grew in multilayers forming foci 
containing refractile and disordered cells (Fig. 3C). For meas-
uring the growth in liquid culture, cells were plated in dupli-
cate 35 mm dishes in DMEM with 10% FCS and viable cells 
counted on consecutive days. As seen from Fig. 4, while HeLa 
and nr HeLa cells showed similar growth rate, the two PTP-S2 
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Fig. 3. Morphology of control and PTP-S2 overexpressmg cells. A: Immunofluorescent staining of cells grown on coverslips. B: Subconfluent 
culture (X50). C: Three-day post-confluence cells (X50). D: Colonies in soft agar (X 50). 
expressing clones had accelerated growth rates, reaching 2-3 
times greater cell numbers by the 5th day after seeding. We 
determined the saturation density by measuring the number of 
cells present in 4-day post-confluence cultures and it was 
found to be 1.7Xl05/cm2 for the control clones and 
4.9xl05/cm2 for PTP-S expressing clones. 
We next looked for differences in anchorage-independent 
growth of the PTP-S2 overexpressmg clones and found that 
after 2 weeks, D3 and B5 cells formed colonies in soft agar 
which were much larger (0.05-0.5 mm) than colonies formed 
by HeLa or nr HeLa cells (0.01-0.1 mm) (Fig. 3D). 
We also investigated the growth of PTP-S2 overexpressmg 
clones in low serum culture medium. Cells were plated in 
duplicate 35 mm dishes in 10% FCS and after 24 h, cells 
were washed with PBS and medium containing 0%, 1%, 2%, 
4% or 10% serum was added. Four days later, viable cells 
were counted. As can be seen from Fig. 5, growth of control 
cells and HeLa cells was greatly reduced in low serum me-
dium, while PTP-S2 overexpressing cells grew in low serum at 
nearly the same rate as in 10% serum. The control cells were 
unable to proliferate and survive in serum-free medium, 
whereas D3 and B5 cells could grow, though at a lower rate 
compared to serum-containing medium. 
4. Discussion 
Accumulating evidence has shown that PTPases counteract 
the action of tyrosine kinases by dephosphorylating their sub-
strates; in addition they also modulate the activities of Ser, 
Thr and Tyr kinases and regulate intermolecular interactions 
[11-13]. The cellular function of most of the PTPases are not 
yet understood. Overexpression of a PTPase can lead to a 
variety of effects on cell growth and morphology depending 
on the cell type and the PTPase gene employed in the experi-
ment. Thus in the oncogene transformed cells, PTP1B and 
PTP1, have been shown to suppress the transformation phe-
notype [14,15]. Yet, the human homolog of PTP-S4, TCPTP, 
when transfected along with v-fms oncogene shows no effect 
on cell growth; however, a truncated enzyme lacking the C-
terminal non-catalytic domain is found to suppress the onco-
genic potential of v-fms [16]. When introduced into non-trans-
formed cells, the full-length TCPTP exhibits no effect in terms 
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of growth and morphology, while overexpression of the trun-
cated enzyme results in multinuclear cells [17]. On the other 
hand, overexpression of PTP-MEG, a membrane and cyto-
skeletal phosphatase, in COS-7 cells inhibits cell proliferation 
and blocks the ability of anchorage-independent growth [18]. 
Overexpression of the low molecular mass tyrosine phospha-
tase (acid phosphatase) in normal and v-erbB-transformed 
cells results in inhibition of growth and reduced ability of 
colony formation in soft agar [19]. 
Overexpression of the transmembrane tyrosine phospha-
tase, PTPa, enhances the activity of pp60c-src and leads to a 
transformed phenotype [20]. PRL-1, a mitogen induced 20 
kDa PTPase, when overexpressed in NIH3T3 cells enhances 
cell growth [21]. PRL-1 does not show any sequence homol-
ogy to other PTPases including PTP-S2. However, function-
ally PTP-S2 and PRL-1 share certain properties such as nu-
clear location and induction during liver regeneration, in 
addition to their effects on cell growth. Time course of induc-
tion suggests that PRL-1 is an immediate early gene [21] 
whereas PTP-S2 behaves as a delayed early gene [6,7]. There-
fore PRL-1 and PTP-S2 are likely to have different cellular 
targets. 
The effect of overexpression of a tyrosine phosphatase may 
not always be the same as the normal cellular function, par-
ticularly when the overexpression is very high and it alters the 
overall PTPase activity of the cell. In the present study, the 
overexpressed PTP-S2 represents only a very small fraction 
(0.04%) of the total PTPase activity of the cells and the level 
of overexpression is less than or comparable to that present in 
rat fibroblasts. Although further work is required to elucidate 
the role of PTP-S2 in cell proliferation, the results presented 
here suggest that PTP-S2 is involved in the regulation of cell 
proliferation. 
In conclusion, overexpression of PTP-S2 in HeLa cells leads 
to (i) an increase in the rate of cell division, (ii) a loss of 
contact inhibition, (iii) an alteration in the cellular morphol-
ogy and (iv) a reduction in the requirement of serum. These 
observations suggest that PTP-S2 is a positive regulator of cell 
growth. 
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Fig. 4. Growth curves of PTP-S2 overexpressing and control cells. 
Details of the experiment are described in Section 2. The data repre-
sent mean ± SE of 3 experiments done with duplicate dishes. 
1 2 4 
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Fig. 5. Serum requirement of PTP-S2 overexpressing and control 
cells. The data represent mean ± SE of 3 experiments done with du-
plicate dishes. 
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